Studies Needing Volunteers

RESPIRATORY

Multiple studies looking for volunteers with COPD who have one or more flare-ups of COPD a year requiring steroid treatment:

COPD Exacerbation Study #1:

(Course) Investigational medicine is given by injection, participation 1 year, visit payments, free rescue medication for duration of study.

Click below for key qualifications:

COPD Exacerbation Study #2:

(QBW) Investigational medicine is given as a daily pill, participation is 6 months, visit payments, free rescue and maintenance medicine for duration of the study.

Click below for key qualifications:

Looking for volunteers with stable COPD:

(TORONARTO) Investigational medicine given by inhaler, participation 4 weeks, visit payments, free rescue medication. Click below for key qualifications:

Looking for volunteers with Idiopathic Pulmonary Fibrosis (IPF):

(GALACTIC-1) Investigational medicine given by an inhaler, participants can continue taking Ofev or Esbriet, participation 1 year with additional 1 year follow-up. Click below for key qualifications:

CARDIOVASCULAR

Looking for volunteers with a past history of MI, peripheral arterial disease requiring intervention or stroke, and elevated lipoprotein a:

(Horizon) Investigational medicine is given as a daily pill, participation approximately 3 years, visit payments, careful monitoring of cardiovascular status. Click below for key qualifications:

Looking for volunteers age 55 or older with a history or evidence of at least one of the following: Myocardial infarction, Ischemic Stroke or Peripheral Arterial Disease:

(Orion 4) Investigational medicine is given as a subcutaneous injection at month 3 and then every 6 months, participation will last approximately 5 years, visit payments, careful monitoring of cardiovascular status. Click below for key qualifications:

WOMEN’S HEALTH


Coming Later This Year: Maternal RSV Vaccine Study

This study will be enrolling pregnant women to receive an investigational vaccine intended to reduce the frequency of RSV infections in newborns. Dr. Guy Middleton at Dothan OBGYN will be leading this study in Dothan.

RSV Vaccine Study

Volunteers: Pregnant women to receive an investigational vaccine that is intended to reduce the frequency of RSV infection in infants.

Infants born to the immunized volunteers are followed after birth for the incidence of RSV infections or other problems for 6 months.

Study is expected to start later in 2020.